Zofran ODT
Company: GlaxoWellcome
Approval Status: Approved January 1999
Treatment for: Oncology
Areas: Oncology
Possible similar drugs: Zofran
General Information
Other Useful Resources
Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
